Skip to main content
IBEX
NASDAQ Technology

IBEX Reports Record Q2 Revenue & EPS, Raises Full-Year Guidance

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
8
Price
$35
Mkt Cap
$460.712M
52W Low
$21.64
52W High
$42.99
Market data snapshot near publication time

Summary

IBEX Ltd announced record second fiscal quarter results, with revenue up 16.7% and adjusted EPS up 46.3%, leading the company to raise its full-year fiscal 2026 revenue and adjusted EBITDA guidance.


Key Events

  • Record Quarterly Performance

    IBEX reported record second fiscal quarter revenue of $164.2 million, a 16.7% increase year-over-year, and record diluted EPS of $0.83, up 44.9%.

  • Strong Profitability Growth

    Adjusted EBITDA increased by 25.2% to $20.7 million, with adjusted EPS growing 46.3% to $0.87, driven by higher margin offshore regions and efficient cost management.

  • Raised Fiscal Year 2026 Guidance

    The company raised its fiscal year 2026 revenue guidance to a range of $620-$630 million (from $605-$620 million) and adjusted EBITDA guidance to $80-$82 million (from $78-$81 million).

  • Strategic Investments

    IBEX is making opportunistic investments in AI solutions and increasing sales resources and capacity in top-performing geographies to extend its leadership position.


Analysis

IBEX Ltd delivered a strong second fiscal quarter, reporting record revenue and earnings per share, alongside a significant increase in adjusted EBITDA. The company's revenue growth of 16.7% marks its fourth consecutive quarter of double-digit expansion, driven by strong performance in HealthTech, Travel, Transportation & Logistics, and Retail & E-commerce verticals. The positive momentum is further underscored by the decision to raise full-year fiscal 2026 guidance for both revenue and adjusted EBITDA, indicating management's confidence in continued operational strength and market share gains. Investors should view this as a robust performance, suggesting healthy business fundamentals and an optimistic outlook.

At the time of this filing, IBEX was trading at $35.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $460.7M. The 52-week trading range was $21.64 to $42.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IBEX - Latest Insights

IBEX
May 13, 2026, 4:53 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $30.50
Real-time Price: $30.92 info
Change: +$0.420 (+1%) info
Market Cap: $413.991M info
IBEX
May 13, 2026, 9:04 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $31.22
Real-time Price: $30.92 info
Change: -$0.300 (-0.96%) info
Market Cap: $413.991M info
IBEX
May 06, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $29.00
Real-time Price: $30.92 info
Change: +$1.92 (+7%) info
Market Cap: $413.991M info
IBEX
May 06, 2026, 4:27 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $29.00
Real-time Price: $30.92 info
Change: +$1.92 (+7%) info
Market Cap: $413.991M info
IBEX
May 05, 2026, 9:02 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $28.25
Real-time Price: $30.92 info
Change: +$2.67 (+9%) info
Market Cap: $413.991M info
IBEX
Feb 05, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.00
Real-time Price: $30.92 info
Change: -$4.08 (-12%) info
Market Cap: $413.991M info